Jean De Gunzburg will attend the 8th Annual Microbiome Connect: Europe 2022 on July 6-7 2022 and participate as a speaker to the panel discussion on ‘Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy’ scheduled on July 6th, at 11.30am CET.
The 8th Annual Microbiome Connect: Europe 2022 is dedicated to showcasing the leading drug development and consumer product platforms applying live microbial consortia, engineered microbes, and microbial-derived metabolites for therapeutic and health applications in patients and consumers.
As the first EMA approved microbiome-targeted therapeutics emerge on the horizon, drug developers will have the opportunity to benchmark their rational drug platforms, targeting validated pathways in gastrointestinal, neurological, metabolic disorders, as well as oncology-based indications.
The event will take place in Amsterdam on July 6-7, 2022.
Website event link here.